A detailed history of National Bank Of Canada transactions in Pro Mis Neurosciences Inc. stock. As of the latest transaction made, National Bank Of Canada holds 421 shares of PMN stock, worth $421. This represents 0.0% of its overall portfolio holdings.

Number of Shares
421
Previous 421 -0.0%
Holding current value
$421
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$1.2 - $2.27 $105 - $199
88 Added 26.43%
421 $0
Q3 2022

Oct 13, 2022

BUY
$4.99 - $9.25 $1,661 - $3,080
333 New
333 $2,000

Others Institutions Holding PMN

About ProMIS Neurosciences Inc.


  • Ticker PMN
  • Exchange OTC
  • Description
  • ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms t...
More about PMN
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.